Oathstar

H.Res. 803 · 119th Congress · Health

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

In committee Introduced Oct 10, 2025 Latest action Oct 10, 2025

What it does

The Congressional Research Service hasn’t published a summary of this bill yet. Summaries usually follow within a few weeks of introduction.

Roll call votes

No recorded roll call votes on this bill. Most bills never get one; many pass by voice vote or unanimous consent, or stay in committee.

Latest action

Oct 10, 2025 · Referred to the House Committee on Energy and Commerce.